DEA Telemedicine Compliance
People are asking...
My provider won’t continue my TRT without yearly face-to-face visit which they say is law. Are you similar or does it vary by state?...
That's not the law yet, per the DEA's temporary rule. https://www.dea.gov/press-releases/2023/05/09/dea-samhsa-extend-covid-19-telemedicine-flexibilities-prescribing [1]. But to be fair to the provi... See Full Answer
I want to start with a telemedicine clinic but I’m worried about what I’ve read on the rules changing in November with the dea requiring A in doctor v...
I'm going to copy another recent reply we made to this comment, if you don't mind, and expand on it. The main issue with the TRT telemedicine concerns is focused on other controlled substances & tele... See Full Answer
Do you foresee patients currently dependent on TRT to sort of be “screwed” at any point due to increased regulations that make it so they can no longe...
I don’t have a crystal ball, but I don’t see that being a problem. Treatment is becoming more prevalent because we are better at recognizing the symptoms, more open about talking about it, and recent ... See Full Answer
Have a question? Ask us.
At AlphaMD, we're here to help. Feel free to ask us any question you would like about TRT, medical weightloss, ED, or other topics related to men's health. Or take a moment to browse through our past questions.
How does Telemedicine compliance current work with the live rules, laws, and regulations evolving in healthcare today?
Both the DEA and HHS extended telemedicine flexibilities for prescription of controlled substances until December 31, 2024 as of their statement released on September 29.
https://www.federalregister.gov/documents/2023/10/10/2023-22406/second-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled
"In light of the need to further evaluate the best course of action given the comments received in response to the NPRMs and the presentations at the Telemedicine Listening Sessions, DEA, jointly with HHS, is issuing this second temporary rule (“Second Temporary Rule”) extending the full set of telemedicine flexibilities regarding prescription of controlled medications as were in place during the COVID–19 PHE, through December 31, 2024. This extension authorizes all DEA-registered practitioners to prescribe schedule II–V controlled medications via telemedicine through December 31, 2024, whether or not the patient and practitioner established a telemedicine relationship on or before November 11, 2023. In other words, the grace period provided in the First Temporary Rule is effectively subsumed by this Second Temporary Rule, which continues the extension of the current flexibilities for all practitioner-patient relationships—not just those established on or before November 11, 2023—until the end of 2024.
The purpose of this Second Temporary Rule, like the one before it, is to ensure a smooth transition for patients and practitioners that have come to rely on the availability of telemedicine for controlled medication prescriptions, as well as allowing adequate time for providers to come into compliance with any new standards or safeguards. DEA is working to promulgate new standards or safeguards by the fall of 2024."
This extension authorizes all DEA-registered practitioners to prescribe schedule II–V controlled medications via telemedicine through December 31, 2024, whether or not the patient and practitioner established a telemedicine relationship on or before November 11, 2023. In other words, the grace period provided in the First Temporary Rule is effectively subsumed by this Second Temporary Rule, which continues the extension of the current flexibilities for all practitioner-patient relationships—not just those established on or before November 11, 2023—until the end of 2024.
Even as of January 1, 2025 if the old rules go into effect, so long as the patient was referred to us by their PCP, it is still perfectly acceptable to prescribe controlled substances to patients without a physical exam.
https://www.dea.gov/press-releases/2023/02/24/dea-announces-proposed-rules-permanent-telemedicine-flexibilities
"The proposed rules also would not affect:
Telemedicine consultations and prescriptions by a medical practitioner to whom a patient has been referred, as long as the referring medical practitioner has previously conducted an in-person medical examination of the patient."
Have a question? Ask us.
At AlphaMD, we're here to help. Feel free to ask us any question you would like about TRT, medical weightloss, ED, or other topics related to men's health. Or take a moment to browse through our past questions.
People are asking...
My provider won’t continue my TRT without yearly face-to-face visit which they say is law. Are you similar or does it vary by state?...
That's not the law yet, per the DEA's temporary rule. https://www.dea.gov/press-releases/2023/05/09/dea-samhsa-extend-covid-19-telemedicine-flexibilities-prescribing [1]. But to be fair to the provi... See Full Answer
I want to start with a telemedicine clinic but I’m worried about what I’ve read on the rules changing in November with the dea requiring A in doctor v...
I'm going to copy another recent reply we made to this comment, if you don't mind, and expand on it. The main issue with the TRT telemedicine concerns is focused on other controlled substances & tele... See Full Answer
Do you foresee patients currently dependent on TRT to sort of be “screwed” at any point due to increased regulations that make it so they can no longe...
I don’t have a crystal ball, but I don’t see that being a problem. Treatment is becoming more prevalent because we are better at recognizing the symptoms, more open about talking about it, and recent ... See Full Answer
Get $30 off your first month’s order
Enter your email address now to receive $30 off your first month’s cost, other discounts, and additional information about TRT.
Legal Disclaimer
This website is a repository of publicly available information and is not intended to form a physician-patient relationship with any individual. The content of this website is for informational purposes only. The information presented on this website is not intended to take the place of your personal physician's advice and is not intended to diagnose, treat, cure, or prevent any disease. Discuss this information with your own physician or healthcare provider to determine what is right for you. All information is intended for your general knowledge only and is not a substitute for medical advice or treatment for specific medical conditions. The information contained herein is presented in summary form only and intended to provide broad consumer understanding and knowledge. The information should not be considered complete and should not be used in place of a visit, phone or telemedicine call, consultation or advice of your physician or other healthcare provider. Only a qualified physician in your state can determine if you qualify for and should undertake treatment.